Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
22nd Century (XXII)
NASDAQ:XXII
Holding XXII?
Track your performance easily
XXII Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.58 - $110.24
Previous Close$0.87
Volume224.54K
Average Volume (3M)408.43K
Market Cap
$6.83M
Enterprise Value$21.90M
Total Cash (Recent Filing)$1.52M
Total Debt (Recent Filing)$16.59M
Price to Earnings (P/E)―
Beta1.10
Next Earnings
Aug 07, 2024EPS Estimate
-$4.96Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-102.71
Shares Outstanding8,292,518
10 Day Avg. Volume1,065,630
30 Day Avg. Volume408,429
Standard Deviation0.28
R-Squared0.07
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)-0.42
Price to Sales (P/S)0.15
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.31
Enterprise Value/Gross Profit-2.52
Enterprise Value/Ebitda-0.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
22nd Century News
PremiumCompany Announcements
22nd Century Group Faces Ongoing Financial Challenges
PremiumCompany Announcements
22nd Century Surpasses Nasdaq Equity Requirements
PremiumCompany Announcements
22nd Century Secures IP Deal for Nicotine Reduction Research
PremiumCompany Announcements
22nd Century Capital Raise and Strategic Financing Moves
PremiumCompany Announcements
22nd Century to Participate in Emerging Growth ConferenceRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
XXII FAQ
What was 22nd Century’s price range in the past 12 months?
22nd Century lowest stock price was $0.58 and its highest was $110.24 in the past 12 months.
What is 22nd Century’s market cap?
Currently, no data Available
When is 22nd Century’s upcoming earnings report date?
22nd Century’s upcoming earnings report date is Aug 07, 2024 which is 108 days ago.
How were 22nd Century’s earnings last quarter?
22nd Century released its earnings results on May 15, 2024. The company reported -$1.72 earnings per share for the quarter, beating the consensus estimate of -$5.28 by $3.56.
Is 22nd Century overvalued?
According to Wall Street analysts 22nd Century’s price is currently Overvalued.
Does 22nd Century pay dividends?
22nd Century does not currently pay dividends.
What is 22nd Century’s EPS estimate?
22nd Century’s EPS estimate is -$4.96.
How many shares outstanding does 22nd Century have?
22nd Century has 7,897,518 shares outstanding.
What happened to 22nd Century’s price movement after its last earnings report?
22nd Century reported an EPS of -$1.72 in its last earnings report, beating expectations of -$5.28. Following the earnings report the stock price went up 1.935%.
Which hedge fund is a major shareholder of 22nd Century?
Among the largest hedge funds holding 22nd Century’s share is GMT Capital Corp. It holds 22nd Century’s shares valued at N/A.
---
22nd Century Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
XXII Sentiment 100%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Decreased
By 6.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $9.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.5%
Last 30 Days ▼ 10.5%
Last 30 Days ▼ 10.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-97.59%
12-Months-Change
Fundamentals
Return on Equity
-346.39%
Trailing 12-Months
Asset Growth
-80.17%
Trailing 12-Months
Company Description
22nd Century
22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on September 12, 2005 and is headquartered in Clarence, NY.
---
XXII Earnings Call
Q1 2024
0:00 / 0:00
---
XXII Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---